SynopsisErwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also .....
SynopsisImatinib is a medication used to treat cancer. The global Gleevec market size is expected to reach US$ 595.2 million by 2029, growing at a CAGR of 8.5% from 2023 to 2029. The market is mainly driven by the significant applications of Gleevec in various e.....
SynopsisImatinib is a medication used to treat cancer. The global Imatinib Mesylate Drugs market size is expected to reach US$ 595.2 million by 2029, growing at a CAGR of 8.5% from 2023 to 2029. The market is mainly driven by the significant applications of Imat.....
SynopsisPonatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL). The global Ponatinib market size is expected to reach US$ .....
SynopsisPonatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL). The global Ponatinib Drugs market size is expected to reac.....
SynopsisIclusig is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL). The global Iclusig market size is expected to reach US$ 360.4 mill.....
SynopsisMarqibo (vinCRIStine sulfate LIPOSOME injection) is vincristine encapsulated in sphingomyelin/cholesterol liposomes for intravenous administration. The global Vincristine Sulfate Liposome Injection market size is expected to reach US$ 502.1 million by 20.....
SynopsisMarqibo (vinCRIStine sulfate LIPOSOME injection) is vincristine encapsulated in sphingomyelin/cholesterol liposomes for intravenous administration. The global Vincristine Sulfate Liposome Injection Drugs market size is expected to reach US$ 502.1 million.....
SynopsisMarqibo (vinCRIStine sulfate LIPOSOME injection) is vincristine encapsulated in sphingomyelin/cholesterol liposomes for intravenous administration. The global Marqibo market size is expected to reach US$ 351.2 million by 2029, growing at a CAGR of 6.9% f.....
SynopsisPegaspargase is a modified enzyme used as an antineoplastic agent. It is a form of L-asparaginase which has undergone PEGylation. The global Pegaspargase market size is expected to reach US$ 505.9 million by 2029, growing at a CAGR of 8.2% from 2023 to 2.....








